Influx Healthtech Balance Sheet Annual

BSE: - | NSE: INFLUX | ISIN: INE0MYZ01012 | Sector: Biotechnology & Drugs

271.00 -3.80 (-1.38%)Updated : 11 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	123.70	-	41.10	28.30
Cash Equivalents	25.17	-	0.00	0.00
Other Liabilities Total	0.23	-	0.34	0.22
Common Stock Total	23.15	-	0.03	0.03
Other Current Assets Total	0.35	-	0.02	0.00
Total Assets	123.70	-	41.10	28.30
Total Equity	100.76	-	22.87	11.65
Retained Earnings( Accumulated Deficit)	77.61	-	6.50	6.50
Total Common Shares Outstanding	2.32	-	2.32	2.32
Tangible Book Valueper Share Common Eq	43.50	-	9.87	5.02
Total Liabilities	22.95	-	18.23	16.65
Short Term Investments	2.30	-	0.70	0.00
Cashand Short Term Investments	27.47	-	3.61	3.55
Total Receivables Net	37.72	-	16.27	14.14
Accounts Receivable- Trade Net	33.78	-	15.92	13.83
Property/ Plant/ Equipment Total- Net	31.02	-	13.71	6.30
Total Current Liabilities	22.71	-	17.89	16.39
Total Inventory	15.93	-	5.74	2.34
Accounts Payable	19.12	-	14.37	13.45
Other Currentliabilities Total	3.59	-	3.20	2.17
Intangibles Net	0.05	-	0.02	0.03
Other Long Term Assets Total	1.98	-	1.46	1.15
Note Receivable- Long Term	9.19	-	0.23	0.76
period Length	0.00	-	0.00	0.00
Total Current Assets	81.46	-	25.68	20.06
Accumulated Depreciation Total	-	-	-2.90	-1.05
Accrued Expenses	-	-	0.00	0.00
Long Term Debt	-	-	0.00	0.03
Other Equity Total	-	-	16.35	5.13
Prepaid Expenses	-	-	0.05	0.03
Current Portof LT Debt/ Capital Leases	-	-	0.03	0.05
Cash	-	-	2.91	3.55
Property/ Plant/ Equipment Total- Gross	-	-	16.61	7.35
Total Debt	-	-	0.32	0.80
Notes Payable/ Short Term Debt	-	-	0.29	0.72
Deferred Income Tax	-	-	0.00	0.01
Total Long Term Debt	-	-	0.00	0.03